RAGE: A journey from the complications of diabetes to disorders of the nervous system - Striking a fine balance between injury and repair

Restorative Neurology and Neuroscience

Volumn 23, Issue 5-6, 2005, Pages 355-365

  Ling, Ling Rong ^a   Gooch, Clifton ^a   Szabolcs, Mattias ^a   Herold, Kevan C ^a   Lalla, Evanthia ^a   Hays, Arthur P ^a   Shi, Fang Yan ^a   Yan, Shirley Shi Du ^a   Schmidt, Ann Marie ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Ligands; Nerve crush; Neurodegeneration; Receptor; Regeneration

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; CALGRANULIN; HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN S 100;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS; GLYCATION; HOMEOSTASIS; INJURY; NERVE DEGENERATION; NERVE FIBER TRANSECTION; NERVE REGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; STRESS; TOXICITY; UPREGULATION;

ANIMALS; DIABETES COMPLICATIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; HMGB1 PROTEIN; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; STRESS; WOUND HEALING;

EID: 28544448713     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. M. M. Anderson, J. R. Requena, J.R. Crowley, S.R. Thorpe and J. Heinecke, The myeloperoxidase system of human phagocytes generates Nepsilon- (carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation endproducts at sites of inflammation, J Clin Invest 104 (1999), 103-113.
2. U. Andersson, H. Wang, K. Palmblad, A.C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, M. Yang and K.J. Tracey, High mobility group 1 protein (HMG 1) stimulates proinflammatory cytokine synthesis in human monocytes, J. Exp. Med. 192 (2000), 565-570.
3. O. Arancio, H.P. Zhang, X. Chen, C. Lin, F. Trinchese, D. Puzzo, S. Liu, A. Hegde, S.F. Yan, A. Stern, J.S. Luddy, L.F. Lue, D.g. Walker, A. Roher, M. Buttini, L. Mucke, W. Li, A.M. Schmidt, M. Kindy, P.A. Hyslop, D.M. Stern and S.S.D. Yan, RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice, EMBO J 23 (2004), 4096-4105.
4. T. Arumugam, D.M. Simeone, A.M. Schmidt and C.D. Logsdon, S100P stimulates cell proliferation and survival via RAGE, J. Biol. Chem. 279 (2004), 5059-5065.
5. K.J. Bar, S. Franke, B. Wenda, S. Muller, R. Kientsch-Engel, G. Stein and H. Sauer, Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer disease and vascular dementia, Neurobiol Aging 24 (2003), 333-338.
6. M. Brownlee, Glycation products and the pathogenesis of diabetic complications, Diabetes Care 15 (1992), 1835-1843.
7. L.G. Bucciarelli, T. Wendt, W. Qu, Y. Lu, E. Lalla, L.L. Rong, M.T. Goova, B. Moser, T.K. Kislinger, D.C. Lee, Y. Kashyap, D.M. Stern and A.M. Schmidt, RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E null mice, Circ 106 (2002), 2827-2835.
8. T. Chavakis, A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K.T. Preissner and P.P. Nawroth, The Pattern Recognition Receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment, J. Exp. Med. 198 (2003), 1507-1515.
9. Y. Chen, S.S. Yan, J. Colgan, H.P. Zhang, J. Luban, A.M. Schmidt, D. Stern and K.C. Herold, Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products, J. Immunol 173 (2004), 1399-1405.
10. D.K. Chou, J. Zhang, F.I. Smith, P. McCaffery and F.B. Jungalwala, Developmental expression of receptor for advanced glycation endproducts (RAGE), amphoterin and sulfoglucuronly (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration, J Neurochem 90 (2004), 1389-1401.
11. S.M. Chou, C.Y. Han, H.S. Wang, H. Vlassara and R. Bucala, A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical study, J Neurol Sci 169 (1999), 87-92.
12. F. Cipollone, A. Iezzi, M. Fazia, M. Zucchelli, B. Pini, C. Cuccurullo, D. De Cesare, G. De Blasis, R. Muraro, R. Bei, F. Chiarelli, A.M. Schmidt, F. Cuccurullo and A. Mezzetti, The Receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control, Circ 108 (2003), 1070-1077.
13. R. Deane, S. Du Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, F. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A.M. Schmidt, D.L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern and B. Zlokovic, RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain, Nat Med 9 (2003), 907-913.
14. R. Deane, Z. Wu and B.V. Zlokovic, RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier, Stroke 35 (2004), 2628-2631.
15. R. Dei, A. Takeda, H. Niwa, M. Li, Y. Nakagomi, M. Watanabe, T. Inagaki, Y. Washimi, Y. Yasuda, K. Horie, T. Miyata and G. Sobue, Lipid peroxidation and advanced glycation endproducts in the brain in normal aging and in Alzheimer's disease, Acta Neuropathol 104 (2002), 113-122.
16. R. Donato, S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles, Intl J Biochem Cell Biol 33 (2001), 637-668.
17. S.Y. Fu and T. Gordon, The cellular and molecular basis of peripheral nerve regeneration, Mol Neurobiol 14 (1997), 67-116.
18. X. Girones, A. Guuimera, C.Z. Cruz-Sanchez, A. Ortega, N. Sasaki, Z. Makita, J.V. Lafuente, R. Kalaria and F.F. Cruz-Sanchez, N epsilon carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease, Free Radic Biol Med 36 (2004), 1241-1247.
19. M.T. Goova, J. Li, T. Kislinger, W. Qu, Y. Lu, L.G. Bucciarelli, S. Nowygrod, B.M. Wolf, X. Caliste, S.F. Yan, D.M. Stern and A.M. Schmidt, Blockade of Receptor for AGE (RAGE) restores effective wound healing in diabetic mice, American J Pathol 159 (2001), 513-525.
20. S. Guazzi, A. Strangio, A.T. Franzi and M.E. Bianchi, HMGB1, an architectural chromatin protein and extracellular signaling factor, has a spatially and temporally restricted expression pattern in mouse brain, Gene Expr Patterns 3 (2003), 29-33.
21. K.M. Haslbeck, A. Bierhaus, S. Erwin, A. Kirchner, P. Nawroth, U. Schlotzer, B. Neundorfer and D. Heuss, Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor kappa B activation in vasculitic neuropathy, Muscle Nerve 29 (2004), 853-860.
22. M.A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M.F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern and A.M. Schmidt, RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides, Cell 97 (1999), 889-901.
23. M.A. Hofmann, S. Drury, B.I. Hudson, M.R. Gleason, W. Qu, Y. Lu, E. Lalla, S. Chitnis, J. Monteiro, M.H. Stickland, L.G. Bucciarelli, B. Moser, G. Moxley, S. Itescu, P.J. Grant, P.K. Gregersen, D.M. Stern and A.M. Schmidt, RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response, Genes Immun 3 (2002), 123-135.
24. O. Hori, J. Brett, T. Slattery, R. Cao, J. Zhang, J. Chen, M. Nagashima, D. Nitecki, J. Morser, D. Stern and A.M. Schmidt, The Receptor for Advanced Glycation Endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system, J. Biol. Chem. 270 (1995), 25752-25761.
25. K. Ikeda, T. Higashi, H. Sano, Y. Jinnouchi, M. Yoshida, T. Araki, S. Ueda and S. Horiuchi, Carboxymethyllysine protein adduct is a major immunological epitope in proteins modified with AGEs of the Maillard reaction, Biochem 35 (1996), 8075-8083.
26. T. Jono, T. Kimura, J. Takamatsu, R. Nagai, K. Miyazaki, T. Yuzuriha, T. Kitamura and S. Horiuchi, Accumulation of imidazolone, pentosidine, and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons in aged human brain, Pathol Int 52 (2002), 563-571.
27. S. Kikuchi, K. Shinpo, A. Ogata, S. Tsuji, M. Takeuchi, Z. Makita and K.Tashiro, Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord, Amyotroph Lateral Scler Other Motor Neuron Disord 3 (2002), 63-68.
28. T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, S.D. Yan, M. Hofmann, S.F. Yan, M. Pischetsrider, D. Stern and A.M. Schmidt, Ne (carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signaling pathways and modulate gene expression, J Biol Chem 274 (1999), 31740-31749.
29. T. Kislinger, N. Tanji, T. Wendt, W. Qu, Y. Lu, L.J. Ferran, Jr., A. Taguchi, K. Olson, L. Bucciarelli, M. Goova, M.A. Hofmann, G. Cataldegirmen, V. D'Agati, M. Pischetsrieder, D. Stern and A.M. Schmidt, RAGE mediates inflammation and enhanced expression of tissue factor in the vasculature of diabetic apolipoprotein E null mice, Arterio Thromb Vasc Biol 21 (2001), 905-910.
30. P. Küry, G. Stoll and H.W. Müller, Molecular mechanisms of cellular interactions in peripheral nerve regeneration, Curr Opin Neurol 14 (2001), 635-639.
31. E. Lalla, I.B. Lamster, M. Feit, L. Huang, A. Spessot, W. Qu, T. Kislinger, Y. Lu, D.M. Stern and A.M. Schmidt, Blockade of RAGE suppresses periodontitis-associated alveolar bone loss in diabetic mice, J. Clin. Invest 105 (2000), 1117-1124.
32. M. Li and L.F.B. Nicholson, Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus, Brain Research 1018 (2004), 10-17.
33. L.F. Lue, D. Walker, L. Brachova, J. Rogers, Y. Shen, A.M. Schmidt, D.M. Stern and S.D. Yan, Involvement of RAGE-microglial interactions in Alzheimer's disease: in vivo and in vitro studies, Exp. Neurol. 171 (2001), 17810-17814.
34. S. Mruthinti, J.J. Buccafusco, W.D. Hill, J.L. Waller, T.W. Jackson, E.Y. Zamrini and R.F. Schade, Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides, Neurobiol Aging 25 (2004), 1023-1032.
35. S. Mruthinti, W.D. Hill, S. Swamy-Mruthinti and J.J. Buccafusco, Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites, J Mol Neurosci 20 (2003), 223-232.
36. M. Neeper, A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, Y.C. Pan, K. Elliston, D. Stern and A. Shaw, Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins, J Biol Chem 267 (1992), 14998-15004.
37. J. Nieke and M. Schachner, Expression of neural cell adhesion molecules L1 and N-CAM and their common carbohydrate epitope L2/HNK-1 during development and after transection of the mouse sciatic nerve, Differentiation 30 (1985), 141-151.
38. J. S. Park, D. Svetkauskaite, Q. He, J.Y. Kim, D. Strassheim, A. Ishizaka and E. Abraham, Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein, J. Biol. Chem. 279 (2004), 7370-7377.
39. L. Park, K.G. Raman, K.J. Lee, Y. Yan, L.J. Ferran, W.S. Chow, D. Stern and A.M. Schmidt, Suppression of accelerated diabetic atherosclerosis by soluble Receptor for AGE (sRAGE), Nature Medicine 4 (1998), 1025-1031.
40. R. Pullerits, I.M. Jonsson, M. Verdrengh, M. Bokarewa, U. Andersson, N. Erlandsson-Harris and A. Tarkowski, High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis, Arthritis Rheum 48 (2003), 1693-1700.
41. H. Rauvala and R. Pihlaskari, Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons, J. Biol. Chem. 262 (1987), 16625-16635.
42. S. Reddy, J. Bichler, K. Wells-Knecht, S.R. Thorpe, and J.W. Baynes, Carboxymethyllysine is a dominant AGE antigen in tissue proteins, Biochem 34 (1995), 10872-10878.
43. L.L. Rong, A. Adebayo, Y. Lu, S. Przedborski, A.P. Hays, S.F. Yan and A.M. Schmidt, Microglial RAGE accelerates mortality and neuronal dysfunction in a murine model of familial amyotrophic lateral sclerosis, Society for Neuroscience (2004).
44. L.L. Rong, W. Trojaborg, W. Qu, K. Kostov, S.D. Yan, C. Gooch, M. Szabolcs, A.P. Hays and A.M. Schmidt, Antagonism of RAGE suppresses peripheral nerve regeneration, FASEB Journal 18 (2004), 1812-1817.
45. L.L. Rong, S.F. Yan, T. Wendt, D. Hans-Wagner, S. Pachydaki, L.G. Bucciarelli, A. Adebayo, W. Qu, Y. Lu, K. Kostov, E. Lalla, S.D. Yan, C. Gooch, M. Szabolcs, W. Trojaborg, A.P. Hays and A.M. Schmidt, RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways, FASEB Journal 18 (2004), 1818-1825.
46. L.L. Rong, S.F. Yan, S.D. Yan, D. Hans-Wagner, F. Song, D.M. Stern, S. Prezedborski, A.P. Hays and A.M. Schmidt, RAGE-dependent mechanisms accelerate neuronal dysfunction in a murine model of amyotrophic lateral sclerosis, Society for Neuroscience (2002).
47. T. Sakaguchi, S.F. Yan, S.D. Yan, L.L. Rong, M. Sousa, D. Belov, M. Andrassy, S.P. Marso, S. Duda, B. Arnold, B. Liliensiek, P.P. Nawroth, D.M. Stern, A.M. Schmidt and Y. Naka, Arterial restenosis: central role of RAGE-dependent neointimal expansion, J Clin Invest 111 (2003), 959-972.
48. N. Sasaki, M. Takeuchi, H. Chowei, S. Kikuchi, Y. Hayashi, N. Nakano, H. Ikeda, S. Yamagishi, T. Kitamoto, T. Saito and Z. Makita, Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques, Neurosci Lett 326 (2002), 117-120.
49. N. Sasaki, S. Toki, H. Chowei, T. Saito, N. Nakano, Y. Hayashi, M. Takeuchi and Z. Makita, Immunohistochemical distribution of the receptor for advanced glycation endproducts in neurons and astrocytes in Alzheimer's disease, Brain Res 888 (2001), 256-262.
50. B.W. Schafer and C.W. Heinzmann, The S100 family of EF-hand calcium-binding proteins: functions and pathology, Trends Biochem Sci 21 (1996), 134-140.
51. E. Schleicher, E. Wagner and A. Nerlich, Increased accumulation of glycoxidation product carboxymethyllysine in human tissues in diabetes and aging, J Clin Invest 99 (1997), 457-468.
52. A.M. Schmidt, O. Hori, J. Chen, J.F. Li, J. Crandall, J. Zhang, R. Cao, S.D. Yan, J. Brett and D. Stern, Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1): a potential mechanism for the accelerated vasculopathy of diabetes, J. Clin. Invest. 96 (1995), 1395-1403.
53. A.M. Schmidt, M. Vianna, M. Gerlach, J. Brett, J. Ryan, J. Kao, C. Esposito, H. Hegarty, W. Hurley, M. Clauss, F. Wang, Y.C. Pan, Y.C. Tsang and D. Stern, Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface, J Biol Chem 267 (1992), 14987-14997.
54. A.M. Schmidt, S.D. Yan, J. Brett, R. Mora and D. Stern, Regulation of mononuclear phagocyte migration by cell surface binding proteins for advanced glycosylation endproducts, J. Clin. Invest. 92 (1993), 2155-2168.
55. N. Shibata, A. Hirano, S. Kato, R. Nagai, S. Horiuchi, T. Komori, T. Umahara, K. Asayama and M. Kobayashi, Advanced glycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation, Acta Neuropathol (Berl) 97 (1999), 240-246.
56. W.D. Snider, F.Q. Zhou, J. Zhong and A. Markus, Signaling the pathway to regeneration, Neuron 35 (2002), 13-16.
57. M.M. Sousa, S. Du Yan, R. Fernandes, A. Guimaraes, D. Stern and M.J. Saraiva, Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways, J Neurosci 21 (2001), 576-586.
58. M.M. Sousa, S.D. Yan, D. Stern and M.J. Saraiva, Interaction of the receptor for advanced glycation endproducts (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation, Lab Invest 80 (2000), 1101-1110.
59. A. Taguchi, D.C. Blood, G. del Toro, A. Canet, D.C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M.A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D.M. Stern and A.M. Schmidt, Blockade of amphoterin/RAGE signaling suppresses tumor growth and metastases, Nature 405 (2000), 354-360.
60. N. Tanji, G.S. Markowitz, C. Fu, T. Kislinger, A. Taguchi, M. Pischetsrieder, D. Stern, A.M. Schmidt and V.D. D'Agati, The expression of Advanced Glycation Endproducts and their cellular receptor RAGE in diabetic nephropathy and non-diabetic renal disease, J. American Soc. Nephrol. 11 (2000), 1656-1666.
61. A. Tauer, T. Knerr, T. Niwa, T.P. Schaub, C. Lage, J. Passlick-Deetjen and M. Pischetsrieder, In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis, Biochem Biophys Res Comm 280 (2001), 1408-1414.
62. L.J. Van Eldik and M.S. Wainwright, The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain, Restor Neurol Neurosci 21 (2003), 97-108.
63. H. Wang, O. Bloom, M. Zhang, J.M. Vishnuhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K.R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P.E. Molina, N.N. Abumrad, A. Sama and K.J. Tracey, HMG-1 as a late mediator of endotoxin lethality in mice, Science 285 (1999), 248-251.
64. J. L. Wautier, C. Zoukourian, O. Chappey, M-P. Wautier, P-J. Guillausseau, R. Cao, O. Hori, D. Stern and A.M. Schmidt, Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation endproducts blocks hyperpermeability, J. Clin. Invest. 97 (1996), 238-243.
65. T.M. Wendt, N. Tanji, J. Guo, T.R. Kislinger, W. Qu, Y. Lu, L.G. Bucciarelli, L.L. Rong, B. Moser, G.S. Markowitz, G. Stein, A. Bierhaus, B. Liliensiek, B. Arnold, P.P. Nawroth, D.M. Stern, V.D. D'Agati and A.M. Schmidt, RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy, Am J Pathol 162 (2003), 1123-1137.
66. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, G. Godman, D. Stern and A.M. Schmidt, RAGE and amyloid-b peptide neurotoxicity in Alzheimer's disease, Nature 382 (1996), 685-691.
67. S.D. Yan, X. Chen, A.M. Schmidt, J. Brett, G. Godman, C.W. Scott, C. Caputo, T. Frappier, S.H. Yen and D. Stern, The presence of glycated tau in Alzheimer's disease: a mechanism for induction of oxidant stress, PNAS (USA) 91 (1994), 7787-7791.
68. S.S.D. Yan, Z.Y. Wu, H.P. Zhang, G. Furtado, X. Chen, S.F. Yan, A.M. Schmidt, C. Brown, A. Stern, J. LaFaille, L. Chess, D.M. Stern and H. Jiang, Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system, Nature Medicine 9 (2003), 287-293.
69. S.D. Yan, H. Zhu, A. Zhu, A. Golabek, H. Du, A. Roher, J. Yu, C. Soto, A.M. Schmidt, D. Stern and M. Kindy, Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis, Nature Medicine 6 (2000), 643-651.
70. Z. Zhou, K. Wang, M.S. Penn, S.P. Marso, M.A. Lauer, F. Forudi, X. Zhou, W. Qu, Y. Lu, D.M. Stern, A.M. Schmidt, A.M. Lincoff and E.J. Topol, Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury, Circ 107 (2003), 2238-2243.
71. D.B. Zimmer, E.H. Cornwall, A. Landar and W. Song, The S100 protein family: history, function, and expression, Brain Res Bull 37 (1995), 417-429.